Cannabis Stock News- Investing in Cannabis and Hemp Stocks

Thursday, March 30, 2017

Cannabis Stock News: The Hydropothecary Corporation (TSX VENTURE: $THCX) Receives License to Sell Cannabis Oil

GATINEAU, QC - March 30, 2017 (Investorideas.com Newswire) The Hydropothecary Corporation (TSX VENTURE: THCX) (the "Company"), a licensed producer and distributor of medical cannabis, is pleased to announce it has received an amendment to its licence from Health Canada under the Access to Cannabis for Medical Purposes Regulations (Canada) (the "ACMPR") to include the sale of cannabis oils from its facility in Gatineau, QC. The Company's license under the ACMPR was amended from production only and provides the Company with the ability to sell cannabis oil products to registered patients under the ACMPR along with its current dried medical cannabis products.

The Company received an amendment to its licence under the ACMPR to produce cannabis oils in August 2015 and has been focused on the development of a new innovative oil product line. In anticipation of this approval to sell cannabis oil extracts, the Company has been producing cannabis oil and extracts. Sales are anticipated to begin late Spring 2017.

"This is another significant milestone in the Hydropothecary growth story and provides our clients with yet another way in which to consume their medicinal cannabis without smoking" said Sebastien St-Louis, Co-Founder and Chief Executive Officer.

About The Hydropothecary Corporation

The Hydropothecary Corporation is an authorized licensed producer and distributor of medical marijuana licensed by Health Canada under the Access to Cannabis for Medical Purposes Regulations (Canada). Hydropothecary provides naturally grown and rigorously tested medical marijuana of uncompromising quality. Hydropothecary's branding, marijuana product offering, patient service standards and product pricing are consistent with THC's positioning as a premium brand for a legal source for medical marijuana within this new marketplace. In addition to medical marijuana production and sales, Hydropothecary explores various research and development opportunities for cannabinoid extracts, drugs and combinatory chemistry. In addition, the company is investigating the development and patenting of novel technologies related to medical marijuana, as well as the import and export of medical marijuana.

Forward-Looking Information

This press release contains forward-looking information based on current expectations.

Statements about market making activities and TSXV approvals, among others, are forward-looking information. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information, please contact:

Sebastien St-Louis
Chief Executive Officer
The Hydropothecary Corporation
1-866-438-THCX (8429)
invest@THCX.com

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks

Watch the 420 Cannabis Investor video

https://www.youtube.com/watch?v=e2zFezO580Y&t=54s

More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

#Cannabis Stock News: Algae Dynamics Corp (OTCQB: $ADYNF) Revised Business Strategy To Include Product Development Using Other Botanicals Such As Cannabis And Hemp

#Cannabis Stock News: Algae Dynamics Corp (OTCQB: $ADYNF) Revised Business Strategy To Include Product Development Using Other Botanicals Such As Cannabis And Hemp

TORONTO, CANADA - March 30, 2017 (Investorideas.com Newswire) ALGAE DYNAMICS CORP (OTCQB: ADYNF) (the "Company" or "ADC"), a development stage company previously focused solely on commercialization of its proprietary BiloSilo™ system for the cultivation of highly-pure algae biomass, today announced a formal re-alignment of its business focus and strategy.

The Company had previously announced, in December 2016, that it was considering ways to capitalize on synergies between its focus on algae cultivation and algae oil extraction, and oil extractions from other botanicals such as cannabis and hemp. The result of these efforts is a new strategy to develop unique health and nutraceutical products utilizing cannabis, hemp and algae oils. Management believes that this strategy engenders both an immediate product development opportunity leading to near-term revenue and a longer-term vertically-integrated sustainable enterprise approach.

The revised strategy resulted in a seven-step program for 2017 aimed at rapid implementation of this strategy, as follows:

Research Agreement with University of Waterloo to investigate the use of cannabis oil in the context cancer - $600,000, three-year program (signed February 24, 2017).
Research Agreement with University of Western Ontario to investigate the use of cannabis derivatives for the development of novel pharmacotherapies for mental health - C$1,000,000, four-year program (signed March 13, 2017).
Collaboration Agreement with ARA – Avanti Rx Analytics, a company approved by Health Canada, to extract, purify, manufacture, sell, import/export medical marijuana products (signed March 15, 2017).
Sign supply agreements with cannabis producers, licensed by Health Canada.
Select location suitable for future cannabis production.
Apply to Health Canada for licence to produce, sell, import/export medical cannabis.
Develop collaboration opportunity with pharmaceutical company.

Paul Ramsay, Chairman and President of the Company said, "We believe this revised corporate strategy will allow us to build value for all stakeholders over both the near and longer terms. In the short-term we are fast-tracking to revenue growth. In the longer term, we believe we have a sustainable enterprise-building opportunity in a rapidly expanding market."

The full slide deck is available at: http://www.algaedynamics.com/files/ADC-Company-PPT-March-28-2017.pdf

Read this release in full at http://www.investorideas.com/CO/ADYNF/news/2017/03301Strategy.asp or http://www.investorideas.com/420cannabisinvestorideas/

About Algae Dynamics Corp

ADC is currently engaged in the development of unique health products and pharmaceuticals that utilize hemp, cannabis and algae oils. This is an extension of our plan to commercialize our proprietary BioSilo(R) algae cultivation system for the high volume, low cost production of pure contaminant-free algae biomass which is high in Omega-3 fatty acids. We have engaged two Canadian universities to provide research into the use of extracts from cannabis oil, which we plan to use to develop products that combine the significant health benefits of Omega-3s derived from algae oil and extracts from cannabis oil. Our research is focusing on the use of cannabis oil in the context of cancer, and the use of cannabis derivatives for the development of novel pharmacotherapies for mental health.

NOTE REGARDING FORWARD-LOOKING STATEMENTS

This news release contains "forward-looking statements" as that term is defined in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, use of proceeds and the development, costs and results of current or future actions and opportunities in the sector. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies, our ability to raise the additional funding we will need to continue to pursue our exploration and development program, and our ability to retain important members of our management team and attract other qualified personnel. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

FOR MORE INFORMATION, PLEASE CONTACT:

Paul Ramsay
Phone: 289-997-6740
Email: ramsay@algaedynamics.com

www.algaedynamics.com

ALGAE DYNAMICS CORP (OTCQB: ADYNF) is a featured company on the 420 Cannabis Investor Ideas of 2017 at www.420cannabisinvestorideas.com

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp Disclosure Algae Dynamics Corp (OTCQB: ADYNF) is a featured cannabis company on 420 Cannabis Investor Ideas - learn more www.420cannabisinvestorideas.com Companies pay up to 1000 dollars for the directory listing . Disclaimer: This directory is not a recommendation to buy or sell securities or products or services Investorideas.com charges a fee for placement. The directory is not an endorsement or recommendation but meant to be an investor resource/ due diligence tool.

Wednesday, March 29, 2017

22nd Century Invited to Speak at the Colorado Hemp Expo about the Company's Medical Marijuana Initiatives and Zero-THC Hemp Plants

CLARENCE, N.Y. - March 29, 2017 (Investorideas.com Newswire) 22nd Century Group, Inc. (NYSE MKT:XXII), a leader in tobacco harm reduction and cannabis research, announced today that representatives of the Company's wholly-owned subsidiary, Botanical Genetics, have been invited to serve as featured speakers and presenters at the annual Colorado Hemp Expo at the Ranch Events Complex, 5260 Arena Circle, Loveland, Colorado on Friday, March 31, 2017, and Saturday, April 1, 2017.

Dr. Paul Rushton, Vice President of Plant Biotechnology, and Thomas James, Esq., Vice President & General Counsel, will provide conference attendees with business and scientific updates and highlights of 22nd Century's advances in the rapidly evolving legal medical marijuana and industrial hemp markets. Headlining the presentation will be Dr. Rushton's featured speech on Friday evening regarding the Company's proprietary cannabis initiatives, including the Company's recently announced development of THC-free industrial hemp plants and the propagation of medical marijuana strains that are selected for increased levels of medically-important cannabinoids, such as CBC and CBD. Dr. Rushton will also speak in a panel discussion on Seeds, Clones, Pesticides and Pollen at the conference. Mr. James will speak on three panel discussions: Investments in Hemp, Global Hemp Activities, and The Future of Hemp. Dr. Rushton, Mr. James and other representatives of the Company will be available for one-on-one meetings throughout the conference.

"We are developing several exciting new strains of medical marijuana as well as industrial hemp varieties with substantially altered levels of cannabinoids - all of which will be below the legal limit of 0.3% THC," explained Dr. Rushton. "Following our recently announced success with Zero-THC hemp plants and our major collaboration with the University of Virginia, Botanical Genetics is now aggressively expanding our activities in an effort to make our Company a major source of proprietary plants for both the legal medical marijuana and industrial hemp markets. We look forward to exploring exciting business opportunities with like-minded companies in Colorado."

About 22nd Century Group, Inc.

22nd Century is a plant biotechnology company focused on technology which allows us to increase or decrease the level of nicotine in tobacco plants and the level of cannabinoids in cannabis plants through genetic engineering and plant breeding. The Company's primary mission in tobacco is to reduce the harm caused by smoking. The Company's primary mission in cannabis is to develop proprietary cannabis strains for important new medicines and agricultural crops. 22nd Century currently owns or exclusively controls more than 200 issued patents and more than 50 pending patent applications around the world. For more information, visit www.xxiicentury.com and www.botanicalgenetics.com.

Cautionary Note Regarding Forward-Looking Statements: This press release contains forward-looking information, including all statements that are not statements of historical fact regarding the intent, belief or current expectations of 22nd Century Group, Inc., its directors or its officers with respect to the contents of this press release, including but not limited to our future revenue expectations. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend" and similar expressions and variations thereof are intended to identify forward-looking statements. We cannot guarantee future results, levels of activity or performance. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances, or to reflect the occurrence of unanticipated events. You should carefully review and consider the various disclosures made by us in our annual report on Form 10-K for the fiscal year ended December 31, 2016, filed on March 8, 2017, including the section entitled "Risk Factors," and our other reports filed with the U.S Securities and Exchange Commission which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected.

Contacts

22nd Century Group, Inc.
Investor Relations:
IRTH Communications
Andrew Haag, 866-976-4784
xxii@irthcommunications.com

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks

Watch the 420 Cannabis Investor video

https://www.youtube.com/watch?v=e2zFezO580Y&t=54s

More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Cannabis Stock News: Mentor Capital (OTCQB: $MNTR) Book Value up 66% to $5.6M Today, in 2016 10-K

G Farma, GWPH, Bhang and Cash Total $5.4M for Marijuana and Cannabis M&A Leader

SAN DIEGO - March 29, 2017 (Investorideas.com Newswire) Mentor Capital, Inc. (OTCQB: MNTR) announced that it has filed its annual 10-K filing for the year ended December 31, 2016 with the SEC.

The Company reports that for the year ended December 31, 2016, Mentor had revenues of $2,761,245 and gross profit of $976,085 with a resulting net loss of ($858,113) or (4.8 cents) per share. This is an improvement in revenue from the year ended December 31, 2015, revenues of $2,561,758. For the year ended December 31, 2015, Mentor experienced a net loss of ($799,868) or (5.1 cents) per share.

The Mentor Capital, Inc. parent company has no non-affiliate debt, and raised $1,542,961 from approximately 20 shareholders during the year ended December 31, 2016, under the authority of an 11 USC 1145 order and $523,520 from warrant redemption fees at $0.10 per warrant from designees redeeming unexercised warrants that have been called but were not exercised timely. The Company invested $25,000 into cannabis related companies during the year and the Company maintained a cash balance of $1,311,338 at December 31, 2016, compared to $73,679 at December 31, 2015. The Company closed the year ended December 31, 2016, with a book value of $4,051,629, up from $3,374,882 at the end of 2015.

Mentor Capital, Inc. had 7,575 shareholders reported as of December 31, 2016, with 20,980,510 shares issued. There were 8,206,390 Series D warrants outstanding at the December 31, 2016, year-end at a strike price of $1.60 per share, and 689,159 Series H warrants are held by an investment bank at a $7.00 per share strike price. During 2016, Mentor sold 222,223 shares of unregistered share for $100,000. No new equity was granted to directors, insiders, consultants or investor relations firms in 2016. A long-term 300,000 share repurchase plan was authorized in 2014 and at December 31, 2016, a total of 44,748 shares have been repurchased under the long-term plan. The Company's shares finished the year at a closing price of $1.06 per share representing a market capitalization of $22,239,341 compared to a 2015 year ending closing price of $0.27 per share and a corresponding market capitalization of $4,388,834. As of March 27, 2017, the closing price of the Company's shares was $2.44 which results in a corresponding market capitalization of $54,690,268.

The Company is managed by CEO Chet Billingsley (64), who founded Mentor Capital first as an acquisition partnership in 1985. He was qualified as a Registered Investment Advisor and received his undergraduate education at West Point before receiving a Master's Degree in Applied Physics at Harvard University. His early career was at General Electric. CFO Lori Stansfield, CPA (57), was most recently Director of Audit Services for a regional CPA firm. She graduated Magna cum Laude in accounting and received a Master's Degree from the University of Colorado. Ms. Stansfield is certified as a public accountant in both Colorado and California. The four non-officer directors are independent and each has been or is a business owner and major shareholder. Altogether, the directors and officers hold a 29.53% interest in Mentor Capital with Mr. Billingsley's interest reported at 22.90%.

On December 29, 2016, Mentor obtained a judgment in the amount of $1,921,534 against Bhang Corporation and its predecessor in interest, Bhang Chocolate Company, Inc., in the United States District Court for the Northern District of California related to an action filed by Mentor on August 11, 2014, seeking rescission of the February 28, 2014, co-operative funding agreement with Bhang Corporation ("Bhang Agreement") and return of the $1,500,000 paid by the Company to Bhang. The judgment accrues interest at the rate of 10% from December 29, 2016, until such time as the judgment is satisfied. Mentor intends to enforce this judgment. As part of the judgment Bhang owners, Scott Van Rixel and Richard Sellers, who together purchased 117,000 shares pursuant to the Bhang Agreement have the option to return all or part of those shares in exchange for payment of the original purchase price of $1.95 per share plus a pro-rata amount of $58,568 in interest for such returned shares. Mentor will account for the return of the shares as a capital transaction if and when the shares are remitted back to the Company. See Note 4 to consolidated financial statements.

From January 1, 2017, through March 22, 2017, the Company raised $1,765,733 from the exercise of warrants into Common Stock and $56,490 from warrant redemption fees at $0.10 per warrant from designees redeeming unexercised warrants that have been called but were not exercised timely.

In February 2017, the management of GVS stated that they have another entity from which they plan to operate their Puerto Rico operations and they intend to register shares from that entity rather than register the GVS shares they agreed to per the Company's consulting agreement with GVS. The Company holds 500,000 shares in GVS, originally valued at $50,000, which have been fully impaired at December 31, 2016.

In March 2017, the Company invested $1,049,086 in GW Pharmaceuticals PLC Common Stock.

On March 22, 2017, the Company entered into a Notes Purchase Agreement, effective March 17, 2017, with G Farmalabs Limited ("G Farma") under which the Company loaned G Farma an aggregate principal amount of $500,000 under two secured convertible promissory notes. In addition, G Farma exchanged an interest in certain assets and certain rights to register its stock publicly in exchange for 222,223 restricted shares of the Company's Common Stock in a private placement at a price of $2.25 per share for an aggregate purchase price of $500,002. See Note 26 in the consolidated financial statements.

The 10-K includes December 31, 2016, audited financials and can be referenced through the SEC's EDGAR system at: https://www.sec.gov/edgar/searchedgar/companysearch.html

Inputting the company name, Mentor Capital, Inc. or the Company's CIK code which is 0001599117, will bring up the report. The 10-K can also be viewed at the Company's web site at the Investor's Corner section under the Disclosures tab.

About Mentor Capital:

The Company seeks to come alongside and assist private medical marijuana and cannabis companies and their founders in meeting their liquidity and financial objectives, to add protection for investors and to help incubate private cannabis companies. Additional important information for investors is presented at: www.MentorCapital.com.

This press release is neither an offer to sell, nor a solicitation of offers to purchase, securities.

Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the federal securities laws, including statements concerning financial projections, financing activities, corporate combinations, product development activities and sales and licensing activities. Such forward-looking statements are not guarantees of future results or performance, are sometimes identified by words of condition such as "should," "could," "expects," "may," "intends," "seeks," "looks," "moves," or "plans" and are subject to a number of risks and uncertainties, known and unknown, that could cause actual results to differ materially from those intended or anticipated. Such risks include, without limitation: nonperformance of investments, partner and portfolio difficulties, potential delays in marketing and sales, problems securing the necessary financing to continue operations, problems involving continued illegality of cannabis products, potential of competitive products, services, and technologies, difficulties experienced in product development, in recruiting knowledgeable personnel and in protecting intellectual property. Further information concerning these and other risks is included in the Company's Form 10 filing which, along with other very important information about the Company, can be found here: http://mentorcapital.com/disclosures/

The Company undertakes no obligation to update or revise such forward-looking statements to reflect new information, events or circumstances occurring after the date of this press release.

Contacts

Mentor Capital, Inc.
Chet Billingsley, CEO
(760) 788-4700

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks

Watch the 420 Cannabis Investor video

https://www.youtube.com/watch?v=e2zFezO580Y&t=54s

More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Tuesday, March 28, 2017

Hoban Law Group Sponsors Hemp Summit at NoCo Hemp Expo Featured Speakers Include Managing Partner Bob Hoban

Denver, CO - March 28, 2017 (Investorideas.com Newswire) The 4th Annual 2017 NoCo Hemp Expo, March 31st-April 1st at The Ranch Events Complex in Loveland, CO brings together regional, national and international hemp-centric companies. Designed for suppliers, buyers, investors, farmers, processors and manufacturers, the primary focus of this event is to increase awareness of new hemp products, technology, innovation, legislation and politics that impact the advancement of hemp re-entering the mainstream. Last year's event drew more than 3,000 attendees.

The 2nd Annual Hemp Summit on March 31st is a VIP event within the NoCo Hemp Expo that offers an insider's view of the hemp industryand includes hemp-focused investors, founders and professionals. Sponsor Hoban Law Group is the leading cannabusiness legal firm in the US that specializes in business consulting and legal counsel for the entire commercial cannabis industry; serving THC, CBD and hemp business models.

At the Hemp Summit Managing Partner Bob Hobanand Hoban Law Group Associate Garrett Graff will join other industry leaders on a panel covering Industrial Hemp Products & Markets: Good Manufacturing Practices and Consumer Safeguards. Bob will alsogive his own session discussing The Future of Industrial Hemp in America and Beyond, and during NoCo Hemp Expo discuss The Future of Hemp. Vote Hemp board member and counsel to Hoban Law group, Patrick Goggin, will also be featured on a panel discussion during the NoCo Hemp Expomain event, titled Policy Legislation Regulations.

Event Highlights

Friday March 31st:

11:00-11:55 AM - Policy Legislation Regulations NoCo Hemp Expo | Let's Talk Hemp Stage featuring Patrick Goggin, counsel to Hoban Law Group

2:00-2:50 PM - Industrial Hemp Products & Markets: Good Manufacturing Practices and Consumer Safeguards Hemp Summit featuring Bob Hoban&Garrett Graff of Hoban Law Group

4:35-5:00 PM - The Future of Industrial Hemp in America and Beyond Hemp Summit by Bob Hoban

Saturday April 1st:

10:30-11:20 AM - Hemp 101
Noco Expo | Hemp Summit Room
Featuring David Bush of Hoban Law Group

1:30-2:20 PM - Setting the Bar High
NoCo Expo | Hemp Summit Room
Featuring David Bush of Hoban Law Group

3:40-4:00 PM - State of the Industry
NoCo Expo | Let's Talk Hemp Stage by Bob Hoban

See the full NoCo Expo Schedule here

See the full Hemp Summit Schedule here

About Bob Hoban:

DawnDawnBob Hoban and his firm are the nation's go-to legal experts in cannabis business. As professor at the University of Denver in the Law and Society Program, Bob regularly instructs on cannabis and hemp related legal and policy topics, with courses on government regulations, public policy and research-based policy. He has drafted more than 30 bills for the Colorado General Assembly (eminent domain/land use, hemp/marijuana and transportation).

About Hoban Law Group:

Founded in 2008, Hoban Law Group is the leading international law firm specializing in cannabis, CBD and hemp law and policy. Headquartered in Denver, the firm offers expert legal and business law counsel across the United States and in Puerto Rico, Central and South America. Hoban Law Group is at the forefront of the most relevant and prominent issues facing cannabis legalization today, having challenged the recent ruling on hemp and CBD by the DEA and proposing the SB17-17 Post-traumatic Stress Bill in the state of Colorado.

CONTACT:

Gaynell Rogers
Media Relations
gaynellrogers@gmail.com
415-298-1114

Marijuana / Hemp Stocks

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

about Investorideas.com

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .